# Corever in the Treatment of Hypertension

> **NCT02432937** · PHASE3 · COMPLETED · sponsor: **TSH Biopharm Corporation Limited** · enrollment: 134 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Corever

## Key facts

- **NCT ID:** NCT02432937
- **Lead sponsor:** TSH Biopharm Corporation Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-06
- **Final completion:** 2016-08
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2016-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02432937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02432937, "Corever in the Treatment of Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02432937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*